Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
publish chart | backtests Type: candle | line | advanced    Timeframe: intraday | daily | weekly | monthly
IDXX [NASD]
IDEXX Laboratories, Inc.
Healthcare | Diagnostic Substances | USA
financial highlights | statements
Index- P/E25.91 EPS (ttm)3.26 Insider Own0.85% Shs Outstand54.10M Perf Week-2.45%
Market Cap4.57B Forward P/E22.06 EPS next Y3.83 Insider Trans-17.86% Shs Float53.62M Perf Month0.25%
Income182.38M PEG1.81 EPS next Q0.97 Inst Own91.80% Short Float7.85% Perf Quarter-8.37%
Sales1.30B P/S3.51 EPS this Y14.23% Inst Trans-0.68% Short Ratio9.80 Perf Half Y-8.12%
Book/sh11.64 P/B7.26 EPS next Y11.34% ROA16.63% Target Price97.83 Perf Year0.14%
Cash/sh4.22 P/C20.01 EPS next 5Y14.33% ROE30.44% 52W Range81.31 - 101.18 Perf YTD-8.97%
Dividend- P/FCF28.69 EPS past 5Y16.83% ROI27.71% 52W High-17.13% Beta1.07
Dividend %- Quick Ratio1.01 Sales past 5Y6.99% Gross Margin54.37% 52W Low3.13% ATR1.79
Employees5400 Current Ratio1.35 Sales Q/Q2.92% Oper. Margin20.21% RSI (14)37.83 Volatility2.05% 1.81%
OptionableYes Debt/Eq0.42 EPS Q/Q11.99% Profit Margin14.00% Rel Volume0.54 Prev Close84.48
ShortableYes LT Debt/Eq0.00 EarningsApr 23 BMO Payout0.00% Avg Volume429.51K Price83.85
Recom2.20 SMA20-2.96% SMA50-5.48% SMA200-9.97% Volume156,604 Change-0.74%
08-Nov-12Initiated Stifel Nicolaus Hold
29-Aug-12Initiated Canaccord Genuity Hold $92
15-Mar-12Initiated Feltl & Co. Hold $87.50
20-May-10Reiterated Kaufman Bros Buy $77 → $75
27-Apr-10Reiterated Kaufman Bros Buy $70 → $77
07-Apr-10Initiated Kaufman Bros Buy $70
01-Feb-10Downgrade Avondale Mkt Perform → Mkt Underperform $42
15-Jun-09Downgrade Avondale Mkt Outperform → Mkt Perform
15-Oct-08Initiated Avondale Mkt Outperform $55
26-Sep-08Initiated Sun Trust Rbsn Humphrey Neutral
19-Aug-08Initiated Piper Jaffray Buy $63
14-Dec-07Initiated JP Morgan Overweight
24-Aug-07Reiterated CL King Strong Buy $105 → $125
22-May-13 01:00AM  Is IDEXX Laboratories a Fast Cash Machine? at Motley Fool
18-May-13 09:02AM  Don't Get Too Worked Up Over IDEXX Laboratories's Latest Numbers at Motley Fool
14-May-13 05:07PM  IDEXX Labs Ups Stock Buyback at Motley Fool
13-May-13 04:32PM  InPlay: IDEXX Labs announces 4 mln share increase in share repurchase program and refinancing of revolving credit facility Briefing.com
04:30PM  IDEXX Laboratories Announces Increase in Share Repurchase Program and Refinancing of Revolving Credit Facility PR Newswire
09:32AM  IDEXX LABORATORIES INC /DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a Material EDGAR Online
12-May-13 01:00PM  This Family Member Is the Key to Big Investment Gains at Motley Fool
09-May-13 01:12AM  Why IDEXX Laboratories's Earnings Are Outstanding at Motley Fool
30-Apr-13 11:09AM  Pfizer, Zoetis Earnings A Study In Contrasts at Investor's Business Daily
29-Apr-13 11:20AM  3 Earnings Reports That Caught My Attention Last Week at Motley Fool
26-Apr-13 01:04PM  IDEXX LABORATORIES INC /DE Financials EDGAR Online Financials
25-Apr-13 04:14PM  Idexx Rises On Unusually High Volume (IDXX) at TheStreet
23-Apr-13 05:01PM  Idexx Laboratories (IDXX): Today's Featured Health Care Laggard at TheStreet
03:20PM  IDEXX Laboratories Management Discusses Q1 2013 Results - Earnings Call Transcript at Seeking Alpha
10:49AM  IDEXX Laboratories Earnings: Heres Why the Stock is Falling Now at Wall St. Cheat Sheet
07:19AM  InPlay: IDEXX Labs misses by $0.01, misses on revs; guides FY13 EPS below consensus, revs below consensus Briefing.com
07:07AM  Q1 2013 Idexx Laboratories Earnings Release - Before Market Open CCBN
07:00AM  IDEXX Laboratories Announces First Quarter Results PR Newswire
12:01AM  IDEXX LABORATORIES INC /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
15-Apr-13 07:44PM  America's Hidden Obesity Epidemic at Motley Fool
08-Apr-13 04:43PM  IDEXX Laboratories to Release 2013 First Quarter Financial Results PR Newswire
04-Apr-13 04:07PM  IDEXX Laboratories Names Jeffrey Fiarman Executive Vice President and General Counsel PR Newswire
01-Apr-13 02:40PM  Take Advantage of the Stable and Growing Pet Products Industry at Motley Fool
20-Mar-13 04:59PM  Idexx Laboratories Larger Than S&P 500 Component AGL Resources at Forbes
18-Mar-13 12:30PM  Good Long Term Potential With This Healthcare Play at Motley Fool
12-Mar-13 01:05AM  Why the Street Should Love IDEXX Laboratories's Earnings at Motley Fool
10-Mar-13 09:17PM  China government overhaul includes food and drug safety, WSJ says theflyonthewall.com
03-Mar-13 01:55PM  Are Your Stocks Going to the Dogs? Maybe They Should Be at Motley Fool
01-Mar-13 10:45AM  Picking a Promising Pet Stock at Motley Fool
01:04AM  Check this for a Glimpse of IDEXX Laboratories's Future at Motley Fool
23-Feb-13 01:04PM  IDEXX LABORATORIES INC /DE Financials EDGAR Online Financials
20-Feb-13 05:09PM  IDEXX Laboratories Stays On Its Margin Hot Streak at Motley Fool
19-Feb-13 04:53PM  IDEXX LABORATORIES INC /DE Files SEC form 10-K, Annual Report EDGAR Online
14-Feb-13 02:57PM  Cattle-focused biotech ImmuCell sees growth in tough dairy year at bizjournals.com
12-Feb-13 11:20AM  InPlay: IDEXX Labs announces Federal Trade Commission final approval of consent agreement Briefing.com
11:19AM  IDEXX Laboratories Announces Federal Trade Commission Final Approval of Consent Agreement PR Newswire
08-Feb-13 08:28AM  Accuray Beats Despite Wider Loss Zacks
07-Feb-13 11:38AM  Abiomed Beats on EPS, Profit Dips Zacks
06-Feb-13 10:37AM  Travelzoo Director Sells 60.1K Shares and 4 Insider Sales to Track at Wall St. Cheat Sheet
06:00AM  Some Numbers at IDEXX Laboratories that Make Your Stock Look Good at Motley Fool
05:08AM  Strong Defensive Growth Prospects Here at Motley Fool
30-Jan-13 09:06AM  What IDEXX Laboratories's Earnings Headlines Didn't Tell You at Motley Fool
29-Jan-13 06:40PM  IDEXX Laboratories' CEO Discusses Q4 2012 Results - Earnings Call Transcript at Seeking Alpha
03:14PM  Idexx 4Q net income rises 14 pct. AP
07:14AM  InPlay: IDEXX Labs beats by $0.07, misses on revs; guides FY13 EPS in-line, revs above consensus Briefing.com
07:07AM  Q4 2012 Idexx Laboratories Earnings Release - Before Market Open CCBN
07:01AM  IDEXX LABORATORIES INC /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
07:00AM  IDEXX Laboratories Announces Fourth Quarter and Full-Year Financial Results PR Newswire
24-Jan-13 01:52PM  4 Stocks Rising on Big Volume at TheStreet
18-Jan-13 04:52PM  This Industry Leader Is Significantly Undervalued at Motley Fool
17-Jan-13 01:27AM  4:01 pm IDEXX Labs announces CFO Merilee Raines to retire in May 2013 Briefing.com
16-Jan-13 06:07PM  4:01 pm IDEXX Labs announces CFO Merilee Raines to retire in May 2013 Briefing.com
05:25PM  4:01 pm IDEXX Labs announces CFO Merilee Raines to retire in May 2013 Briefing.com
04:44PM  4:01 pm IDEXX Labs announces CFO Merilee Raines to retire in May 2013 Briefing.com
04:24PM  4:01 pm IDEXX Labs announces CFO Merilee Raines to retire in May 2013 Briefing.com
04:12PM  IDEXX LABORATORIES INC /DE Files SEC form 8-K, Change in Directors or Principal Officers EDGAR Online
04:01PM  InPlay: IDEXX Labs announces CFO Merilee Raines to retire in May 2013 Briefing.com
04:00PM  IDEXX Laboratories Announces CFO Merilee Raines to Retire in May 2013 PR Newswire
07-Jan-13 05:05PM  How IDEXX Laboratories Got More Awesome Last Quarter at Motley Fool
04-Jan-13 11:38AM  Neogen Closes Scidera Acquisition Zacks
02-Jan-13 02:35PM  IDEXX Laboratories to Present at J.P. Morgan Healthcare Conference PR Newswire
26-Dec-12 12:30PM  Intuitive Surgical Among Healthcare's Biggest Movers on December 26, 2012 at Investopedia
21-Dec-12 05:11PM  IDEXX Laboratories Announces Federal Trade Commission Preliminary Approval of Consent Agreement PR Newswire
18-Dec-12 04:54PM  Idexx Laboratories Larger Than S&P 500 Component H & R Block at Forbes
12-Dec-12 03:59PM  MWI Vet Stays at Neutral Zacks
11-Dec-12 04:53PM  InPlay from Briefing.com Briefing.com
04:42PM  IDEXX LABORATORIES INC /DE Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E EDGAR Online
04:30PM  InPlay: IDEXX Labs announces entry into consent agreement with FTC Bureau of Competition staff Briefing.com
04:29PM  IDEXX Laboratories Announces Entry Into Consent Agreement with FTC Bureau of Competition Staff PR Newswire
03-Dec-12 08:10PM  Why This Healthcare Stock is Starting to Look Like Good Value at Motley Fool
29-Nov-12 01:00PM  Express Scripts and More Big Movers in Healthcare on November 29, 2012 at Investopedia
16-Nov-12 03:03PM  IDEXX Laboratories to Present at Piper Jaffray 24th Annual Healthcare Conference PR Newswire
12-Nov-12 10:00AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
08-Nov-12 01:47PM  8×8 Initiated at Buy and 4 Initiated Shares on the Move at Wall St. Cheat Sheet
10:08AM  On The Fly: Analyst Initiation Summary theflyonthewall.com
01:23AM  Coverage initiated on IDEXX Labs by Stifel Nicolaus Briefing.com
03-Nov-12 08:57PM  5-Star Stocks Poised to Pop: IDEXX Labs at Motley Fool
02-Nov-12 12:42PM  Piedmont Pharma CEO to speak at UNCG at bizjournals.com
01-Nov-12 02:39PM  What You Might Not Know About Stocks in This Sector at Motley Fool
27-Oct-12 12:48PM  Some Numbers at IDEXX Laboratories that Make Your Stock Look Good at Motley Fool
24-Oct-12 01:04PM  IDEXX LABORATORIES INC /DE Financials EDGAR Online Financials
23-Oct-12 05:08PM  1 Reason IDEXX Laboratories's Earnings Aren't So Hot at Motley Fool
22-Oct-12 09:42AM  New Star Analyst Rankings for IDEXX Laboratories, Inc. StarMine
09:18AM  Idexx Laboratories Earnings Call Insights: New Distribution Agreement, Acceleration in Organic Growth at Wall St. Cheat Sheet
21-Oct-12 09:38AM  New Star Analyst Rankings for IDEXX Laboratories, Inc. StarMine
19-Oct-12 01:48PM  IDEXX Laboratories' CEO Discusses Q3 2012 Results - Earnings Call Transcript at Seeking Alpha
07:11AM  InPlay: IDEXX Labs beats by $0.03, misses on revs; raises FY12 EPS, in-line, sees rev at low end; guides FY13 EPS in-line; revs above consensus Briefing.com
07:07AM  Q3 2012 Idexx Laboratories Earnings Release - Before Market Open CCBN
07:02AM  IDEXX LABORATORIES INC /DE Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements an EDGAR Online
07:00AM  IDEXX Laboratories Announces Third Quarter Results PR Newswire
10-Oct-12 01:33PM  IDEXX Laboratories to Release 2012 Third Quarter Financial Results PR Newswire
04-Oct-12 07:33AM  Zacks Bull and Bear of the Day Highlights: Gap, J. C. Penney, Abaxis, MWI Veterinary Supply and IDEXX Laboratories Zacks
03-Oct-12 04:54PM  Macleod Purchase for Neogen Zacks
03:44PM  Abaxis Inks Deal with MWI Vet Zacks
21-Sep-12 09:14AM  Abaxis Expands Vet Product Line Zacks
12-Sep-12 02:14PM  MWI Vet Remains Neutral Zacks
11:08AM  3 Things to Watch With Pfizer's Zoetis IPO at Motley Fool
10-Sep-12 06:00AM  Under-the-Radar Hot Industries For Small Business Profits TheStreet
06:00AM  Under-the-Radar Hot Industries For Small Business Profits at TheStreet
29-Aug-12 01:54PM  INDEXX Labs INITIATED at Hold and 4 Initiated Shares to Watch at Wall St. Cheat Sheet
IDEXX Laboratories, Inc. develops, manufactures, and distributes various products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets worldwide. The company operates in three segments: Companion Animal Group, Water, and Livestock and Poultry Diagnostics. The company offers point-of-care veterinary diagnostic products comprising instruments and consumables, such as blood and urine chemistry, hematology, quantitative immunoassay testing, and urinalysis analyzers; and rapid assays. It also provides veterinary reference laboratory diagnostic and consulting services; diagnostic and health-monitoring products for livestock and poultry; practice management systems that include hardware, software, and services; and digital imaging systems and services. In addition, the company offers products to test water for microbiological contaminants; and products to test milk for penicillin, amoxicillin, ceftiofur and cephaphirin, tetracycline antibiotic residues, and other contaminants. Further, it provides point-of-care analyzers and related consumables used in human medical hospitals and clinics to measure electrolytes, blood gases, acid-base balance, glucose, lactate, blood urea nitrogen, and ionized calcium, as well as to calculate other parameters, such as base excess and anion gap. Additionally, the company offers consulting services to veterinarians; water testing products to government laboratories, water utilities, and private certified laboratories; livestock and poultry diagnostic products to government and private laboratories that provide testing services to cattle, swine, and poultry veterinarians and producers; and milk testing products to dairy producers and processors. It markets and sells its products through marketing, sales, and technical service groups, as well as independent distributors and other resellers. The company was founded in 1983 and is headquartered in Westbrook, Maine.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
NAQUI ALICorporate Vice PresidentMay 09Option Exercise56.9514,779841,66430,474May 13 04:19 PM
MURRAY ROBERT JDirectorMay 09Option Exercise0.00369016,891May 10 04:09 PM
NAQUI ALICorporate Vice PresidentMay 09Sale87.0012,9611,127,60717,513May 13 04:19 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTMar 15Option Exercise57.915,622325,5767,055Mar 19 11:02 AM
TWIGGE GIOVANICORPORATE VICE PRESIDENTMar 15Sale92.137,055649,9730Mar 19 11:02 AM
DEADY CONAN RCorp VP and General CounselMar 05Option Exercise66.996,030403,9348,255Mar 07 05:31 PM
DEADY CONAN RCorp VP and General CounselMar 05Sale91.726,030553,0962,225Mar 07 05:31 PM
RAINES MERILEEExecutive VP & CFOFeb 25Option Exercise53.2915,871845,70026,577Feb 27 11:59 AM
DEADY CONAN RCorp VP, General Counsel & SecFeb 14Option Exercise45.9111,161512,35810,804Feb 19 07:23 PM
BROWN WILLIAM E IIIExecutive Vice PresidentFeb 14Option Exercise0.00939017,731Feb 19 07:22 PM
AYERS JONATHAN WChairman, President & CEOFeb 14Option Exercise0.006,8000341,996Feb 19 07:20 PM
Williams Michael J PhDExecutive Vice PresidentFeb 14Option Exercise0.001,658010,824Feb 19 07:34 PM
TWIGGE GIOVANICORPORATE VICE PRESIDENTFeb 14Option Exercise0.0036601,570Feb 19 07:33 PM
RAINES MERILEEExecutive VP & CFOFeb 14Option Exercise0.001,822011,622Feb 19 07:32 PM
POWERS JOHNNY DExecutive Vice PresidentFeb 14Option Exercise0.001,38405,592Feb 19 07:30 PM
POLEWACZYK JAMES FCorporate Vice PresidentFeb 14Option Exercise0.001,31807,419Feb 19 07:29 PM
NAQUI ALICorporate Vice PresidentFeb 14Option Exercise0.001,205016,083Feb 19 07:28 PM
Meyaard Daniel VCorporate Vice PresidentFeb 14Option Exercise0.0030404,416Feb 19 07:27 PM
FENNELL GEORGECORPORATE VICE PRESIDENTFeb 14Option Exercise0.001430938Feb 19 07:24 PM
DEADY CONAN RCorp VP, General Counsel & SecFeb 14Sale92.049,622885,6361,182Feb 19 07:23 PM
BROWN WILLIAM E IIIExecutive Vice PresidentFeb 13Option Exercise29.369,533279,88916,792Feb 15 12:08 PM
BROWN WILLIAM E IIIExecutive Vice PresidentFeb 08Option Exercise29.3622,178651,14629,437Feb 12 10:26 AM
BROWN WILLIAM E IIIExecutive Vice PresidentFeb 08Sale93.7822,1782,079,8737,259Feb 12 10:26 AM
RAINES MERILEEExecutive VP & CFOFeb 04Option Exercise39.1099,1483,877,16799,148Feb 05 07:08 PM
RAINES MERILEEExecutive VP & CFOFeb 04Sale93.6789,3488,369,0899,800Feb 05 07:08 PM
RAINES MERILEEExecutive VP & CFOFeb 01Option Exercise34.3713,581466,77951,581Feb 05 07:08 PM
Williams Michael J PhDExecutive Vice PresidentFeb 01Option Exercise55.7623,4321,306,54133,460Feb 05 04:44 PM
Williams Michael J PhDExecutive Vice PresidentFeb 01Sale94.6924,2942,300,4369,166Feb 05 04:44 PM
RAINES MERILEEExecutive VP & CFOFeb 01Sale94.9235,0003,322,3690Feb 05 07:08 PM
RAINES MERILEEExecutive VP & CFOFeb 01Sale94.7951,5814,889,3800Feb 05 07:08 PM
NAQUI ALICorporate Vice PresidentJan 31Option Exercise41.9411,498482,16923,418Feb 04 10:05 AM
RAINES MERILEEExecutive VP & CFOJan 31Sale95.5331,3752,997,30935,000Feb 05 09:13 AM
RAINES MERILEEExecutive VP & CFOJan 31Sale95.3655,0765,252,31438,000Feb 05 09:13 AM
NAQUI ALICorporate Vice PresidentJan 31Sale95.538,540815,82614,878Feb 04 10:05 AM
RAINES MERILEEExecutive VP & CFOJan 09Option Exercise22.717,726175,463153,747Jan 11 03:09 PM
RAINES MERILEEExecutive VP & CFOJan 09Sale97.177,726750,707146,021Jan 11 03:09 PM
BROWN WILLIAM E IIIExecutive Vice PresidentDec 20Option Exercise29.364,087119,9947,259Dec 21 02:06 PM
AYERS JONATHAN WChairman, President & CEODec 18Option Exercise17.1424,164414,050353,297Dec 20 04:26 PM
AYERS JONATHAN WChairman, President & CEODec 18Sale96.0818,1641,745,155335,133Dec 20 04:26 PM
RAINES MERILEEExecutive VP & CFODec 12Option Exercise22.717,726175,463153,747Dec 14 09:49 AM
RAINES MERILEEExecutive VP & CFODec 12Sale95.587,726738,416146,021Dec 14 09:49 AM
BROWN WILLIAM E IIIExecutive Vice PresidentDec 01Option Exercise0.0089203,452Dec 04 04:53 PM
AYERS JONATHAN WChairman, President & CEONov 27Option Exercise17.1420,000342,700393,133Nov 28 02:19 PM
AYERS JONATHAN WChairman, President & CEONov 27Sale92.6715,0001,390,069378,133Nov 28 02:19 PM
RAINES MERILEEExecutive VP & CFONov 14Option Exercise22.717,726175,463153,747Nov 15 04:18 PM
NAQUI ALICorporate Vice PresidentNov 14Sale90.053,504315,53511,920Nov 15 04:24 PM
RAINES MERILEEExecutive VP & CFONov 14Sale90.277,726697,449146,021Nov 15 04:18 PM
AYERS JONATHAN WChairman, President & CEONov 13Option Exercise17.1420,000342,700388,133Nov 15 01:09 PM
AYERS JONATHAN WChairman, President & CEONov 13Sale89.9215,0001,348,753373,133Nov 15 01:09 PM
Williams Michael J PhDExecutive Vice PresidentNov 12Option Exercise33.0416,243536,58923,708Nov 14 01:58 PM
Williams Michael J PhDExecutive Vice PresidentNov 12Sale89.1413,7431,224,9949,965Nov 14 01:58 PM
AYERS JONATHAN WChairman, President & CEONov 09Option Exercise41.942,38499,973368,133Nov 14 01:57 PM
MCKEON BRIAN PDirectorNov 08Option Exercise17.126,666114,08919,007Nov 13 01:19 PM
MCKEON BRIAN PDirectorNov 08Sale90.486,666603,15212,341Nov 13 01:19 PM
AYERS JONATHAN WChairman, President & CEONov 06Option Exercise38.3417,392666,722379,141Nov 08 01:04 PM
RAINES MERILEEExecutive VP & CFONov 06Sale93.8425,0002,346,118146,021Nov 07 02:17 PM
HENDERSON REBECCA MDirectorNov 06Sale94.511,00094,5107,348Nov 07 02:15 PM
AYERS JONATHAN WChairman, President & CEONov 06Sale94.0613,3921,259,673365,749Nov 08 01:04 PM
Williams Michael J PhDExecutive Vice PresidentNov 01Option Exercise28.662,80680,40610,402Nov 05 01:48 PM
Williams Michael J PhDExecutive Vice PresidentNov 01Sale96.022,937282,0067,465Nov 05 01:48 PM
END WILLIAM TDirectorOct 26Sale96.211,970189,53219,093Jan 14 03:33 PM
AYERS JONATHAN WChairman, President & CEOOct 24Option Exercise17.1420,000342,700376,749Oct 26 10:45 AM
AYERS JONATHAN WChairman, President & CEOOct 24Sale96.4215,0001,446,230361,749Oct 26 10:45 AM
DEADY CONAN RCorp VP, General Counsel & SecOct 23Sale97.241,566152,2861,182Oct 25 02:38 PM
AYERS JONATHAN WChairman, President & CEOOct 15Option Exercise38.3420,000766,700371,749Oct 17 02:02 PM
AYERS JONATHAN WChairman, President & CEOOct 15Sale96.7615,0001,451,379356,749Oct 17 02:02 PM
RAINES MERILEEExecutive VP & CFOOct 10Option Exercise22.717,726175,463178,747Oct 11 04:21 PM
RAINES MERILEEExecutive VP & CFOOct 10Sale96.087,726742,313171,021Oct 11 04:21 PM
CRAIG THOMASDirectorSep 14Option Exercise17.498,000139,92018,917Sep 18 02:21 PM
CRAIG THOMASDirectorSep 14Sale99.298,000794,32010,917Sep 18 02:21 PM
AYERS JONATHAN WChairman, President & CEOSep 13Option Exercise17.1420,000342,700366,686Sep 17 02:11 PM
AYERS JONATHAN WChairman, President & CEOSep 13Sale99.2515,0001,488,797351,686Sep 17 02:11 PM
RAINES MERILEEExecutive VP & CFOSep 12Option Exercise22.717,726175,463178,747Sep 14 11:56 AM
RAINES MERILEEExecutive VP & CFOSep 12Sale98.297,726759,368171,021Sep 14 11:56 AM
POWERS JOHNNY DExecutive Vice PresidentSep 10Option Exercise34.371,00034,3704,167Sep 12 02:20 PM
DEADY CONAN RCorp VP, General Counsel & SecSep 06Option Exercise77.592,401186,2948,399Sep 10 03:45 PM
DEADY CONAN RCorp VP, General Counsel & SecSep 06Sale98.594,401433,8843,998Sep 10 03:45 PM
POWERS JOHNNY DExecutive Vice PresidentSep 05Option Exercise34.374,000137,4807,167Sep 06 09:50 AM
POWERS JOHNNY DExecutive Vice PresidentSep 05Sale97.124,000388,4803,167Sep 06 09:50 AM
TWIGGE GIOVANICORPORATE VICE PRESIDENTSep 01Option Exercise0.0026301,190Sep 05 04:54 PM
Meyaard Daniel VCorporate Vice PresidentSep 01Option Exercise0.0081004,020Sep 05 04:11 PM
POLEWACZYK JAMES FCorporate Vice PresidentAug 31Option Exercise46.605,459254,37211,460Sep 05 04:12 PM
POLEWACZYK JAMES FCorporate Vice PresidentAug 31Sale95.015,459518,6616,001Sep 05 04:12 PM
DEADY CONAN RCorp VP, General Counsel & SecAug 29Sale95.312,000190,6205,998Aug 29 02:31 PM
DEADY CONAN RCorp VP, General Counsel & SecAug 27Option Exercise56.953,448196,36417,192Aug 29 02:31 PM
DEADY CONAN RCorp VP, General Counsel & SecAug 27Sale94.819,194871,6837,998Aug 29 02:31 PM
VUMBACCO JOSEPH VDirectorAug 09Option Exercise62.311,50093,4653,560Aug 13 01:06 PM
AYERS JONATHAN WChairman, President & CEOAug 08Option Exercise17.1420,000342,700361,686Aug 10 02:29 PM
RAINES MERILEEExecutive VP & CFOAug 08Option Exercise22.717,726175,463178,747Aug 10 02:30 PM
RAINES MERILEEExecutive VP & CFOAug 08Sale88.847,726686,389171,021Aug 10 02:30 PM
AYERS JONATHAN WChairman, President & CEOAug 08Sale89.4515,0001,341,750346,686Aug 10 02:29 PM
AYERS JONATHAN WChairman, President & CEOAug 01Option Exercise0.0020,0000356,686Aug 03 03:10 PM
NAQUI ALICorporate Vice PresidentAug 01Sale87.845,000439,20015,424Aug 03 03:11 PM
AYERS JONATHAN WChairman, President & CEOAug 01Sale88.0615,0001,320,957341,686Aug 03 03:10 PM
AYERS JONATHAN WChairman, President & CEOJul 25Option Exercise0.0020,0000351,686Jul 27 02:06 PM
AYERS JONATHAN WChairman, President & CEOJul 25Sale87.2815,0001,309,240336,686Jul 27 02:06 PM
Williams Michael J PhDCorporate Vice PresidentJun 01Option Exercise0.001,29908,071Jun 05 03:01 PM
POWERS JOHNNY DCorporate Vice PresidentJun 01Option Exercise0.001,29903,529Jun 05 02:58 PM
FENNELL GEORGECORPORATE VICE PRESIDENTJun 01Option Exercise0.007800989Jun 05 02:56 PM
open in yahoo | open in reuters | open in google